List of works - Francesca Musumeci

An Update On Dual Src/Abl Inhibitors ⬇️

scientific article published on April 1, 2012

Bcr-Abl tyrosine kinase inhibitors: a patent review

scientific article published on 06 February 2015

CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction

scientific article

Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment

scientific article published on 20 September 2018

Fyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors ⬇️

scientific article published on January 1, 2011

Hck inhibitors as potential therapeutic agents in cancer and HIV infection

scientific article

Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines

scientific article published on 18 July 2019

Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma

scientific article published on 19 December 2016

In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity

scientific article published on 01 June 2019

In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold

scientific article

Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809.

scientific article published on 6 October 2017

Optimization of Aminoimidazole Derivatives as Src Family Kinase Inhibitors

scientific article published on 17 September 2018

PYRROLO[2,3-d]PYRIMIDINES AS KINASE INHIBITORS.

scientific article published on 3 March 2017

Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia

scientific article published on 09 November 2018

SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells

scientific article published on 19 February 2016

Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors

scientific article published on 29 April 2015

Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction

scientific article published on 13 August 2018

The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells

scientific article published on 25 August 2017

The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells

scientific article published on 17 May 2019

The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cells

scientific article published on 16 May 2019

The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme

scientific article published on 18 November 2017

List of works by Francesca Musumeci

An Update On Dual Src/Abl Inhibitors ⬇️

Bcr-Abl tyrosine kinase inhibitors: a patent review

CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction

Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment

Fyn Kinase in Brain Diseases and Cancer: The Search for Inhibitors ⬇️

Hck inhibitors as potential therapeutic agents in cancer and HIV infection

Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines

Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma

In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity

In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold

Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809.

Optimization of Aminoimidazole Derivatives as Src Family Kinase Inhibitors

PYRROLO[2,3-d]PYRIMIDINES AS KINASE INHIBITORS.

Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia

SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells

Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors

Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction

The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells

The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells

The small molecule SI113 hinders epithelial-to-mesenchymal transition and subverts cytoskeletal organization in human cancer cells

The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme